Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

12.63
+0.07000.56%
Post-market: 12.630.00000.00%16:10 EDT
Volume:64.40K
Turnover:814.41K
Market Cap:2.20B
PE:125.11
High:12.70
Open:12.56
Low:12.55
Close:12.56
52wk High:18.30
52wk Low:9.77
Shares:174.43M
Float Shares:104.00M
Volume Ratio:0.66
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1010
EPS(LYR):2.60
ROE:1.46%
ROA:-1.24%
PB:1.75
PE(LYR):4.86

Loading ...

Dow Jones Top Company Headlines at 1 PM ET: Walmart Shares Slump on Weakest Sales Growth in over Six Years | Super ...

Dow Jones
·
Aug 21

Dow Jones Top Company Headlines at 7 am ET: Alibaba Posts Weaker Earnings Amid Heavy AI Investments | Deere's ...

Dow Jones
·
Aug 20

HCM Raises Earnings Outlook on New Healthcare Property Acquisitions

TIPRANKS
·
Aug 19

Orient Securities Keeps Their Buy Rating on HUTCHMED (China) (HCM)

TIPRANKS
·
Aug 19

CICC Adjusts HUTCHMED Outlook, Lifting Price Target to HK$26 on Strong Trial Results

Stock News
·
Aug 18

Citic Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)

TIPRANKS
·
Aug 18

HUTCHMED Surges Nearly 4% on Positive Late-Stage Trial Results for Combination Therapy

Stock News
·
Aug 17

Hong Kong Stocks Rise on Monday on Tech Gains; Alibaba Rises 2%

MT Newswires Live
·
Aug 17

HUTCHMED Stock Surges on Positive Drug Trial Results for Lung Cancer Therapy Combination

Deep News
·
Aug 17

Hutchmed announces results from Saffron Phase III trial of Orpathys, Tagrisso

TIPRANKS
·
Aug 17

Hutchmed H1 FY26 Net Income Drops to $15.9 Million; Revenue Rises 0.22% to $278.3 Million

Reuters
·
Aug 14

HUTCHMED (China) (HCM) was downgraded to a Hold Rating at Daiwa

TIPRANKS
·
Aug 14

Press Release: Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
Aug 08

AI-Powered Human Capital Management Market in China Surges 505.7% to 241 Million Yuan in 2025

Stock News
·
Aug 07

Press Release: Edgewise Therapeutics Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 06

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

GlobeNewswire
·
Aug 06

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Aug 05

UOB Kay Hian Remains a Buy on HUTCHMED (China) (HCM)

TIPRANKS
·
Aug 04

UBS Adjusts HUTCHMED Target Price to HK$29.5, Maintains Buy Rating

Stock News
·
Aug 03

Huatai Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)

TIPRANKS
·
Aug 01